Roughly 5.1% of U.S. adults may now be using GLP-1 agonists to try to control their weight, according to eHealth.

Ninety-five percent of CEOs surveyed are optimistic about the coming year, and 84% expect economic conditions to improve.

“While many Americans are satisfied with their coverage options for 2026, many are facing significant cost increases and less rich benefits,” said Derrick Duke, CEO of eHealth.

The Blue Cross and Blue Shield carrier told California providers that maintaining accurate practice information is a contractual requirement.